Improving hospice care for older adults with Alzheimer's and related dementias from diverse backgrounds
Official title: Improving hospice care for racial and ethnic minoritized older adults with Alzheimer’s Disease and Related Dementias (ADRD)
Funded at University of California, San Francisco · NIH-11012394 · Data updated 2026-11-12
This study is looking to improve hospice care for older adults with Alzheimer's and related dementias, especially for those from different racial and ethnic backgrounds, by understanding the challenges they face and finding better ways to support them and their families.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | February 1, 2024 |
| Project end | December 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $726,693 |
| NIH project number | 5R01AG085347-02 |
| Project ID | NIH-11012394 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults with Alzheimer's Disease or related dementias, particularly those from Black, Latinx, and Asian American communities.
✕Less likely to help
Patients who do not have Alzheimer's Disease or related dementias, or those who are not part of the racial and ethnic minoritized groups targeted by this research may not benefit.
What this research studies
This research focuses on enhancing hospice care for older adults suffering from Alzheimer's Disease and Related Dementias (ADRD), particularly among racial and ethnic minoritized groups. It aims to understand the barriers these populations face in accessing hospice services and to develop tailored palliative care models that address their unique needs. The study will involve analyzing existing data and conducting interviews to gather insights on the experiences of these patients and their families. By identifying the impact of structural racism on access and quality of care, the research seeks to create more equitable hospice care solutions.
Why it matters
Potential benefit: If successful, this research could lead to improved access and quality of hospice care for older adults with ADRD from racial and ethnic minoritized backgrounds.
How similar studies have gone: While there has been some research on hospice care for general populations, this specific focus on racial and ethnic minoritized groups with ADRD is relatively novel and untested.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Harrison, Krista Lyn — University of California, San Francisco
- Study coordinator: Harrison, Krista Lyn
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.